Welcome to our dedicated page for ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ SEC filings (Ticker: ZIONP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/'s regulatory disclosures and financial reporting.
MCLEAN SCOTT J reported reported sale transactions in this Form 4 filing.
Zions Bancorporation President & COO Scott J. McLean reported a bona fide gift of 6,650 shares of Common Stock on 2026-07-28. The gift was recorded at a per-share price of $0.00 and left him holding 88,988 shares directly. The filing indicates the transaction was not effected under a Rule 10b5-1 trading plan.
Zions Bancorporation Executive Vice President Derek Steward reported an option exercise and same-day share sale. On 2026-07-28 he exercised 894 stock options for Common Stock at $45.65 per share, fully exhausting that option grant, then sold 894 Common shares at $69.65 per share. The option, which had a graded vesting schedule, was originally set to expire on 2027-02-09.
Zions Bancorporation, N.A. reported strong results for the quarter ended June 30, 2026, with net earnings to common shareholders of $452 million and diluted EPS of $3.05, or $1.74 excluding notable items. Results were boosted by a $215 million gain on the sale of Visa Class B‑1 shares and $37 million of net unrealized gains from SBIC investments. Net interest income was $677 million, up 4% year over year, and the net interest margin held at 3.27%, up from 3.17% a year earlier. Customer-related noninterest income reached $182 million, an 11% increase, while adjusted pre-provision net revenue was $332 million, up 10% sequentially and 5% year over year; the efficiency ratio was 62.2%.
Loans and leases were $62.5 billion, up 3% from the prior-year quarter, and total deposits were $76.6 billion, up 4%, with the loan-to-deposit ratio steady at 82%. Credit quality remained solid, with annualized net loan and lease charge-offs at 0.06%, nonperforming assets of $298 million or 0.48% of loans and leases and other real estate owned, and an allowance for credit losses of $707 million or 1.13% of loans and leases. Capital improved, as the estimated CET1 ratio was 11.8% and tangible book value per common share rose 22% year over year to $44.74.
Zions Bancorporation director Aaron Skonnard reported a compensation-related grant of deferred compensation units linked to the company’s common stock. He acquired 432.1980 Deferred Comp units at a reference price of $69.19 per unit, bringing his reported Deferred Comp balance to 40,169.2260 units. According to the disclosure, these phantom stock units are settled in cash upon the earlier of death or retirement, rather than delivering actual shares.
QUINN STEPHEN D reported acquisition or exercise transactions in this Form 4 filing.
ZIONS BANCORPORATION director Stephen D. Quinn received a compensation grant of 698.72 phantom stock units under a Deferred Comp arrangement. The award is tied to the value of Zions common stock at a reference price of $69.19 per unit and will be settled in cash upon the earlier of his death or retirement, rather than in actual shares.
Following this grant, Quinn has 129,860.767 phantom stock units reported in this plan. The transaction is classified as a derivative grant or award, not an open-market purchase or sale of Zions common stock.
Huang Claire A reported acquisition or exercise transactions in this Form 4 filing.
Zions Bancorporation director Claire A. Huang reported a compensation-related award of deferred stock units. She received 439.401 "Deferred Comp" phantom stock units linked to Zions common stock at a reference price of $69.19 per unit. These phantom stock units are settled in cash upon the earlier of death or retirement, rather than in actual shares. Following this award, her reported deferred compensation balance tied to common stock increased to 35,394.393 units. This filing reflects a grant or award, not an open-market purchase or sale of Zions stock.
Lee Vivian S reported acquisition or exercise transactions in this Form 4 filing.
Director Vivian S. Lee received a grant of deferred compensation units linked to Zions Bancorporation common stock. The award covers 414.19 deferred comp units, each valued at $69.19, and increases her deferred comp balance to 29,755.913 units. According to the footnote, these phantom stock units are settled in cash upon the earlier of death or retirement.
Ryan Daniel Joseph reported acquisition or exercise transactions in this Form 4 filing.
Zions Bancorporation director Daniel Joseph received a compensation grant of 1,921 deferred compensation units tied to common stock. The units were valued at $62.02 per underlying share on the grant date and are structured as phantom stock, settled in cash upon retirement or death. Following this award, he holds 1,921 such units directly.
Zions Bancorporation director Daniel Joseph Ryan filed an initial Form 3 reporting his beneficial ownership in the company’s common stock. The filing shows he held no shares of Common Stock as of the reported date, and it does not reflect any buy or sell transaction.